You can buy or sell STRO and other stocks, options, ETFs, and crypto commission-free!
Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. Its products technologies include XpressCF; anti-body drug conjugates; bispecifics and engineered antibodies; and cGMP facility. Read More The company was founded in June 2003 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
PR NewswireMar 5
Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 5, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11 at 2:50 p.m. ET at the Marriott Copley Place in Boston. A live webcast of the presentation will be accessible through the Events and Presentations page of the Investor Relations section of the company's website at www.sutrobio.com. A replay of the webcast will be...
-$0.63 per share
Expected Today, After Hours